Literature DB >> 16932298

Diabetic neuropathies: clinical manifestations and current treatment options.

Aaron Vinik1, Jagdeesh Ullal, Henri K Parson, Carolina M Casellini.   

Abstract

Diabetic neuropathies are a heterogeneous group of disorders that include a wide range of abnormalities. They can be focal or diffuse, proximal or distal, affecting both peripheral and autonomic nervous systems, causing morbidity with significant impact on the quality of life of the person with diabetes, and can result in early death. Distal symmetric polyneuropathy, the most common form of diabetic neuropathy, usually involves small and large nerve fibers. Small-nerve-fiber neuropathy often presents with pain but without objective signs or electrophysiologic evidence of nerve damage, and is recognized as a component of the impaired glucose tolerance and metabolic syndromes. The greatest risk resulting from small-fiber neuropathy is foot ulceration and subsequent gangrene and amputation. Large-nerve-fiber neuropathies produce numbness, ataxia and uncoordination, impairing activities of daily living and causing falls and fractures. A careful history and detailed physical examination are essential for the diagnosis. Symptomatic therapy has become available and newer and better treatment modalities, based on etiologic factors, are being explored with potential for significant impact on morbidity and mortality. Preventive strategies and patient education still remain key factors in reducing complication rates and mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932298     DOI: 10.1038/ncpendmet0142

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  38 in total

1.  Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Authors:  Amanda Boyd; Carolina Casselini; Etta Vinik; Aaron Vinik
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 2.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 3.  Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.

Authors:  Rozita Naseri; Fatemeh Farzaei; Sajad Fakhri; Fardous F El-Senduny; Miram Altouhamy; Roodabeh Bahramsoltani; Farnaz Ebrahimi; Roja Rahimi; Mohammad Hosein Farzaei
Journal:  Daru       Date:  2019-07-27       Impact factor: 3.117

4.  Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.

Authors:  Yogendranathsing Unmar; Mohammad Ishraq Zafar; Feng Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 5.  Physical Training and Activity in People With Diabetic Peripheral Neuropathy: Paradigm Shift.

Authors:  Patricia M Kluding; Sonja K Bareiss; Mary Hastings; Robin L Marcus; David R Sinacore; Michael J Mueller
Journal:  Phys Ther       Date:  2017-01-01

6.  German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity.

Authors:  Etta J Vinik; James F Paulson; Stephanie L Ford-Molvik; Aaron I Vinik
Journal:  J Diabetes Sci Technol       Date:  2008-11

7.  SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy.

Authors:  M C Hannibal; E K Ruzzo; L R Miller; B Betz; J G Buchan; D M Knutzen; K Barnett; M L Landsverk; A Brice; E LeGuern; H M Bedford; B B Worrall; S Lovitt; S H Appel; E Andermann; T D Bird; P F Chance
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

Review 8.  Midkine in nephrogenesis, hypertension and kidney diseases.

Authors:  Waichi Sato; Yuka Sato
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life.

Authors:  N Ovayolu; E Akarsu; E Madenci; S Torun; O Ucan; M Yilmaz
Journal:  Int J Clin Pract       Date:  2008-04-10       Impact factor: 2.503

10.  Barely scratching the surface.

Authors:  Aaron I Vinik
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.